NGS  |  ONCOLOGY  |  PATHOLOGY  |  HEMATOLOGY  |  PRESENTATIONS

NEXT-GENERATION SEQUENCING (NGS) TESTING


ONCOLOGY TESTING


PATHOLOGY SERVICES


HEMATOLOGY TESTING


MAYO CLINIC ORAL, EDUCATION, AND CLINICAL PRESENTATIONS

A list of Mayo Clinic poster presentations can be found here.

June 3

Education Session: Oligometastatic Disease in Prostate Cancer: Treating the Patient or the Scan?
Track(s): Genitourinary (Prostate) Cancer
Location: S406
Time: 3:05 PM - 3:20 PM
Title: Is There a Role for Surgery and If So, When?
Speaker: Jeffrey Karnes, M.D.

Oral Abstract Session:Hematologic Malignancies—Plasma Cell Dyscrasia
Track(s): Hematologic Malignancies—Plasma Cell
Dyscrasia
Location: E354b
Time: 3:24 PM - 3:36 PM
Title: Phase 1/2 trial of ixazomib, cyclophosphamide, and dexamethasone
for newly diagnosed multiple myeloma (NDMM).
Speaker: Martha Lacy, M.D.

Oral Abstract Session:Hematologic Malignancies—Plasma Cell Dyscrasia
Track(s): Hematologic Malignancies—Plasma Cell
Dyscrasia
Location: E354b
Time: 3:24 PM - 3:36 PM
Title: Evolving changes in M-protein (M), quantitative involved
immunoglobulin (Ig), and hemoglobin (Hb) to identify patients (pts)
with ultra high-risk smoldering multiple myeloma (UHR-SMM).
Speaker: Praful Kumar Ravi, M.B., B.Chir.

June 4

Education Session: Defining and Redefining Myeloma
Track(s): Hematologic Malignancies—Plasma Cell
Dyscrasia
Location: S406
Time: 8:00 AM - 8:20 AM
Title: New Diagnostic and Staging Criteria in Myeloma.
Speaker: S. Vincent Rajkumar, M.D.

Education Session: Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, Post-transplant Lymphoproliferative Disorder
Track(s): Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia; Central Nervous System Tumors
Location: E450ab
Time: 1:55 PM - 2:15 PM
Title: Post-transplant Lymphoproliferative Disorder.
Speaker: Thomas Matthew Habermann, M.D.

Education Session: Progress in Myeloproliferative Neoplasms: Are We
Ready?
Track(s): Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant; Clinical Trials; Health Services Research and Quality of Care; Patient and Survivor Care; Tumor Biology
Location: E354b
Time: 1:55 PM - 2:15 PM
Title: Quality of Life Assessment in Myeloproliferative Neoplasms: Main
Course or Side Dish?
Speaker: Ruben A. Mesa, M.D.

Clinical Problems in Oncology Session: Rare Plasma Cell Dyscrasia: Amyloid, Monoclonal Gammopathy of Renal Significance, and Waldenstrom Macroglobulinemia
Track(s): Hematologic Malignancies—Plasma Cell Dyscrasia
Location: E253B
Time: 5:25 PM - 5:45 PM
Title: Monoclonal Gammopathy of Renal Significance and Other Unusual
Plasma Cell Disorders
Speaker: Angela Dispenzieri, M.D.

June 5

Education Session: Training Program Directors' Breakfast
Track(s): Professional Development
Location: S103
Time: 9:18 AM - 9:29 AM
Title: How to Integrate ASCO University Into Your Program
Speaker: Collin T. Zimmerman, M.D.

Oral Abstract Session: Patient and Survivor Care
Track(s): Patient and Survivor Care
Location: Hall D2
Time: 9:18 AM - 9:29 AM
Title: How to Integrate ASCO University Into Your Program
Speaker: Charles L. Loprinzi, M.D.

Oral Abstract Session: Hematologic Malignancies—Lymphoma and Chronic
Lymphocytic Leukemia
Track(s): Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Location: E354b
Time: 11:45 AM - 11:57 AM
Title: PILLAR-2: A randomized, double-blind, placebo-controlled, phase III
study of adjuvant everolimus (EVE) in patients (pts) with poor-risk diffuse large B-cell lymphoma (DLBCL).
Speaker: Thomas E. Witzig, M.D.

Plenary Session: Post-Plenary Discussion Session: Myeloma
Track(s): Special Sessions
Location: S100a
Speaker: Angela Dispenzieri, M.D.

June 6

Education Session: Curing Burnout in Oncology: Mindful Self-Compassion,
Communication, and Practice
Track(s): Professional Development
Location: S504
Time: 9:45 AM - 10:05 AM
Title: Interventions for Burnout in Heathcare Providers
Speaker: Tait D. Shanafelt, M.D.

Clinical Science Symposium: Precision Medicine: Making Progress for Patient
Benefit
Track(s): Tumor Biology
Time: 9:45 AM - 10:05 AM
Title: Does Molecular Testing Help Patients?
Speaker: Alex A. Adjei, M.D., Ph.D.

Meet the Professor Session: How I Treat High-Risk Multiple Myeloma
Track(s): Hematologic Malignancies—Plasma Cell Dyscrasia
Location: E253D
Time: 1:15 PM - 1:35 PM
Title: How I Treat High-Risk Multiple Myeloma
Speaker: Keith Stewart, M.B., Ch.B.; Martha Q. Lacy, M.D.

Education Session: Rehabilitation of Patients and Survivors: Seizing the
Opportunity
Track(s): Patient and Survivor Care; Geriatric Oncology
Location: S100a
Time: 1:55 PM - 2:15 PM
Title: Tools to Develop a High-Quality Cancer Rehabilitaiton Program
Speaker: Andrea L. Cheville, M.D.

Clinical Science Symposium: Integrating New Diagnostics in Lymphoid Malignancies
Track(s): Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Time: 8:24 AM - 8:36 AM
Title: Circulating Tumor DNA: Ready for Prime Time for Risk Stratification?
Speaker: Grzegorz S. Nowakowski, M.D.

June 7

Education Session: Debating Current Controversies in Medical Management of Metastatic Colorectal Cancer
Track(s): Gastrointestinal (Colorectal) Cancer
Location: S100a
Time: 9:45 AM - 10:00 AM
Title: RAS Wild-Type Patients Should Receive Anti-VEGF Therapy in First Line
Speaker: Axel Grothey, M.D.

Clinical Science Symposium: Novel Combination Therapies in Myeloma
Track(s): Hematologic Malignancies—Plasma Cell Dyscrasia
Location: E354b
Time: 9:57 AM - 10:09 AM
Title: Plasma Cell-Directed Monoclonal Antibody Combinations in Myeloma
Speaker: Rafael Fonseca, M.D.

Education Session: Treatment of Premenopausal Women With Endocrine-
Sensitive Breast Cancer
Track(s): Breast Cancer; Patient and Survivor Care
Location: S406
Time: 10:25 AM - 10:45 AM
Title: Managing Hormone Therapy Toxicity in Young Women
Speaker: Kathryn J. Ruddy, M.D.